OrSense obtains FDA clearance to commercialize NBM200 System in US

07:05 EDT 15 May 2019 | Compelo Medical Devices

OrSense is a medical device company that develops and markets non-invasive hemoglobin, pulse, and oximetry measurement systems based on its innovative Occlusion Spectroscopy technology. The OrSense NBM200 device

Original Article: OrSense obtains FDA clearance to commercialize NBM200 System in US

More From BioPortfolio on "OrSense obtains FDA clearance to commercialize NBM200 System in US"